IBDEI05C ; ; 09-FEB-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7095,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,7096,0)
 ;;=V10.42^^46^489^47
 ;;^UTILITY(U,$J,358.3,7096,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7096,1,4,0)
 ;;=4^V10.42
 ;;^UTILITY(U,$J,358.3,7096,1,5,0)
 ;;=5^HX-UTERUS MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,7096,2)
 ;;=^295220
 ;;^UTILITY(U,$J,358.3,7097,0)
 ;;=V10.43^^46^489^19
 ;;^UTILITY(U,$J,358.3,7097,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7097,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,7097,1,5,0)
 ;;=5^HX OF OVARIAN MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7097,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,7098,0)
 ;;=V10.44^^46^489^26
 ;;^UTILITY(U,$J,358.3,7098,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7098,1,4,0)
 ;;=4^V10.44
 ;;^UTILITY(U,$J,358.3,7098,1,5,0)
 ;;=5^HX-FEMALE GENIT MALG NEC
 ;;^UTILITY(U,$J,358.3,7098,2)
 ;;=^295222
 ;;^UTILITY(U,$J,358.3,7099,0)
 ;;=V10.45^^46^489^34
 ;;^UTILITY(U,$J,358.3,7099,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7099,1,4,0)
 ;;=4^V10.45
 ;;^UTILITY(U,$J,358.3,7099,1,5,0)
 ;;=5^HX-MALE GENIT MALIG NOS
 ;;^UTILITY(U,$J,358.3,7099,2)
 ;;=^295223
 ;;^UTILITY(U,$J,358.3,7100,0)
 ;;=V10.46^^46^489^39
 ;;^UTILITY(U,$J,358.3,7100,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7100,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,7100,1,5,0)
 ;;=5^HX-PROSTATIC MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7100,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,7101,0)
 ;;=V10.47^^46^489^43
 ;;^UTILITY(U,$J,358.3,7101,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7101,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,7101,1,5,0)
 ;;=5^HX-TESTICULAR MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7101,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,7102,0)
 ;;=V10.48^^46^489^48
 ;;^UTILITY(U,$J,358.3,7102,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7102,1,4,0)
 ;;=4^V10.48
 ;;^UTILITY(U,$J,358.3,7102,1,5,0)
 ;;=5^PSNL HX MAL NEOPL-EPIDID
 ;;^UTILITY(U,$J,358.3,7102,2)
 ;;=^321226
 ;;^UTILITY(U,$J,358.3,7103,0)
 ;;=V10.49^^46^489^33
 ;;^UTILITY(U,$J,358.3,7103,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7103,1,4,0)
 ;;=4^V10.49
 ;;^UTILITY(U,$J,358.3,7103,1,5,0)
 ;;=5^HX-MALE GENIT MALIG NEC
 ;;^UTILITY(U,$J,358.3,7103,2)
 ;;=^295226
 ;;^UTILITY(U,$J,358.3,7104,0)
 ;;=V10.50^^46^489^46
 ;;^UTILITY(U,$J,358.3,7104,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7104,1,4,0)
 ;;=4^V10.50
 ;;^UTILITY(U,$J,358.3,7104,1,5,0)
 ;;=5^HX-URINARY MALIGNAN NOS
 ;;^UTILITY(U,$J,358.3,7104,2)
 ;;=^295227
 ;;^UTILITY(U,$J,358.3,7105,0)
 ;;=V10.51^^46^489^1
 ;;^UTILITY(U,$J,358.3,7105,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7105,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,7105,1,5,0)
 ;;=5^HX OF BLADDER MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7105,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,7106,0)
 ;;=V10.52^^46^489^10
 ;;^UTILITY(U,$J,358.3,7106,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7106,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,7106,1,5,0)
 ;;=5^HX OF KIDNEY MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7106,2)
 ;;=^295229
 ;;^UTILITY(U,$J,358.3,7107,0)
 ;;=V10.53^^46^489^15
 ;;^UTILITY(U,$J,358.3,7107,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7107,1,4,0)
 ;;=4^V10.53
 ;;^UTILITY(U,$J,358.3,7107,1,5,0)
 ;;=5^HX OF MAL NEOPLASM,RENAL PELVIS
 ;;^UTILITY(U,$J,358.3,7107,2)
 ;;=^323624
 ;;^UTILITY(U,$J,358.3,7108,0)
 ;;=V10.59^^46^489^45
 ;;^UTILITY(U,$J,358.3,7108,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7108,1,4,0)
 ;;=4^V10.59
 ;;^UTILITY(U,$J,358.3,7108,1,5,0)
 ;;=5^HX-URINARY MALIGNAN NEC
 ;;^UTILITY(U,$J,358.3,7108,2)
 ;;=^295230
 ;;^UTILITY(U,$J,358.3,7109,0)
 ;;=V10.60^^46^489^12
 ;;^UTILITY(U,$J,358.3,7109,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7109,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,7109,1,5,0)
 ;;=5^HX OF LEUKEMIA NOS
 ;;^UTILITY(U,$J,358.3,7109,2)
 ;;=^295231
 ;;^UTILITY(U,$J,358.3,7110,0)
 ;;=V10.61^^46^489^14
 ;;^UTILITY(U,$J,358.3,7110,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7110,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,7110,1,5,0)
 ;;=5^HX OF LYMPHOID LEUKEMIA
 ;;^UTILITY(U,$J,358.3,7110,2)
 ;;=^295232
 ;;^UTILITY(U,$J,358.3,7111,0)
 ;;=V10.62^^46^489^18
 ;;^UTILITY(U,$J,358.3,7111,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7111,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,7111,1,5,0)
 ;;=5^HX OF MYELOID LEUKEMIA
 ;;^UTILITY(U,$J,358.3,7111,2)
 ;;=^295233
 ;;^UTILITY(U,$J,358.3,7112,0)
 ;;=V10.63^^46^489^17
 ;;^UTILITY(U,$J,358.3,7112,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7112,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,7112,1,5,0)
 ;;=5^HX OF MONOCYTIC LEUKEMIA
 ;;^UTILITY(U,$J,358.3,7112,2)
 ;;=^295234
 ;;^UTILITY(U,$J,358.3,7113,0)
 ;;=V10.69^^46^489^11
 ;;^UTILITY(U,$J,358.3,7113,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7113,1,4,0)
 ;;=4^V10.69
 ;;^UTILITY(U,$J,358.3,7113,1,5,0)
 ;;=5^HX OF LEUKEMIA NEC
 ;;^UTILITY(U,$J,358.3,7113,2)
 ;;=^295235
 ;;^UTILITY(U,$J,358.3,7114,0)
 ;;=V10.71^^46^489^32
 ;;^UTILITY(U,$J,358.3,7114,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7114,1,4,0)
 ;;=4^V10.71
 ;;^UTILITY(U,$J,358.3,7114,1,5,0)
 ;;=5^HX-LYMPHOSARCOMA
 ;;^UTILITY(U,$J,358.3,7114,2)
 ;;=^295236
 ;;^UTILITY(U,$J,358.3,7115,0)
 ;;=V10.72^^46^489^28
 ;;^UTILITY(U,$J,358.3,7115,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7115,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,7115,1,5,0)
 ;;=5^HX-HODGKIN'S DISEASE
 ;;^UTILITY(U,$J,358.3,7115,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,7116,0)
 ;;=V10.79^^46^489^31
 ;;^UTILITY(U,$J,358.3,7116,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7116,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,7116,1,5,0)
 ;;=5^HX-LYMPHATIC MALIGN NEC
 ;;^UTILITY(U,$J,358.3,7116,2)
 ;;=^295238
 ;;^UTILITY(U,$J,358.3,7117,0)
 ;;=V10.81^^46^489^2
 ;;^UTILITY(U,$J,358.3,7117,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7117,1,4,0)
 ;;=4^V10.81
 ;;^UTILITY(U,$J,358.3,7117,1,5,0)
 ;;=5^HX OF BONE MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7117,2)
 ;;=^295239
 ;;^UTILITY(U,$J,358.3,7118,0)
 ;;=V10.82^^46^489^35
 ;;^UTILITY(U,$J,358.3,7118,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7118,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,7118,1,5,0)
 ;;=5^HX-MALIG SKIN MELANOMA
 ;;^UTILITY(U,$J,358.3,7118,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,7119,0)
 ;;=V10.83^^46^489^42
 ;;^UTILITY(U,$J,358.3,7119,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7119,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,7119,1,5,0)
 ;;=5^HX-SKIN MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,7119,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,7120,0)
 ;;=V10.84^^46^489^6
 ;;^UTILITY(U,$J,358.3,7120,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7120,1,4,0)
 ;;=4^V10.84
 ;;^UTILITY(U,$J,358.3,7120,1,5,0)
 ;;=5^HX OF EYE MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7120,2)
 ;;=^295242
 ;;^UTILITY(U,$J,358.3,7121,0)
 ;;=V10.85^^46^489^3
 ;;^UTILITY(U,$J,358.3,7121,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7121,1,4,0)
 ;;=4^V10.85
 ;;^UTILITY(U,$J,358.3,7121,1,5,0)
 ;;=5^HX OF BRAIN MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7121,2)
 ;;=^295243
 ;;^UTILITY(U,$J,358.3,7122,0)
 ;;=V10.86^^46^489^36
 ;;^UTILITY(U,$J,358.3,7122,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7122,1,4,0)
 ;;=4^V10.86
 ;;^UTILITY(U,$J,358.3,7122,1,5,0)
 ;;=5^HX-MALIGN NERVE SYST NEC
 ;;^UTILITY(U,$J,358.3,7122,2)
 ;;=^295244
 ;;^UTILITY(U,$J,358.3,7123,0)
 ;;=V10.87^^46^489^20
 ;;^UTILITY(U,$J,358.3,7123,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7123,1,4,0)
 ;;=4^V10.87
 ;;^UTILITY(U,$J,358.3,7123,1,5,0)
 ;;=5^HX OF THYROID MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7123,2)
 ;;=^295245
 ;;^UTILITY(U,$J,358.3,7124,0)
 ;;=V10.88^^46^489^24
 ;;^UTILITY(U,$J,358.3,7124,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7124,1,4,0)
 ;;=4^V10.88
 ;;^UTILITY(U,$J,358.3,7124,1,5,0)
 ;;=5^HX-ENDOCRINE MALIGN NEC
 ;;^UTILITY(U,$J,358.3,7124,2)
 ;;=^295246
 ;;^UTILITY(U,$J,358.3,7125,0)
 ;;=V10.89^^46^489^16
 ;;^UTILITY(U,$J,358.3,7125,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7125,1,4,0)
 ;;=4^V10.89
 ;;^UTILITY(U,$J,358.3,7125,1,5,0)
 ;;=5^HX OF MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,7125,2)
 ;;=^295247
 ;;^UTILITY(U,$J,358.3,7126,0)
 ;;=V45.71^^46^490^7
 ;;^UTILITY(U,$J,358.3,7126,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7126,1,4,0)
 ;;=4^V45.71
 ;;^UTILITY(U,$J,358.3,7126,1,5,0)
 ;;=5^ACQUIRED ABSENCE OF BREAST
 ;;^UTILITY(U,$J,358.3,7126,2)
 ;;=^336882
 ;;^UTILITY(U,$J,358.3,7127,0)
 ;;=V45.72^^46^490^6
 ;;^UTILITY(U,$J,358.3,7127,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7127,1,4,0)
 ;;=4^V45.72
 ;;^UTILITY(U,$J,358.3,7127,1,5,0)
 ;;=5^ACQ. ABS. OF INTESTINE (LG,SM)
 ;;^UTILITY(U,$J,358.3,7127,2)
 ;;=^317959
 ;;^UTILITY(U,$J,358.3,7128,0)
 ;;=V45.73^^46^490^8
 ;;^UTILITY(U,$J,358.3,7128,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7128,1,4,0)
 ;;=4^V45.73
 ;;^UTILITY(U,$J,358.3,7128,1,5,0)
 ;;=5^ACQUIRED ABSENCE OF KIDNEY
 ;;^UTILITY(U,$J,358.3,7128,2)
 ;;=^317962
 ;;^UTILITY(U,$J,358.3,7129,0)
 ;;=V45.74^^46^490^4
 ;;^UTILITY(U,$J,358.3,7129,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7129,1,4,0)
 ;;=4^V45.74
 ;;^UTILITY(U,$J,358.3,7129,1,5,0)
 ;;=5^ACQ ABSENCE ORG,URINARY TRACT
 ;;^UTILITY(U,$J,358.3,7129,2)
 ;;=^322063
 ;;^UTILITY(U,$J,358.3,7130,0)
 ;;=V45.75^^46^490^3
 ;;^UTILITY(U,$J,358.3,7130,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7130,1,4,0)
 ;;=4^V45.75
 ;;^UTILITY(U,$J,358.3,7130,1,5,0)
 ;;=5^ACQ ABSENCE ORG,STOMACH
 ;;^UTILITY(U,$J,358.3,7130,2)
 ;;=^322065
 ;;^UTILITY(U,$J,358.3,7131,0)
 ;;=V45.76^^46^490^2
 ;;^UTILITY(U,$J,358.3,7131,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7131,1,4,0)
 ;;=4^V45.76
 ;;^UTILITY(U,$J,358.3,7131,1,5,0)
 ;;=5^ACQ ABSENCE ORG,LUNG
 ;;^UTILITY(U,$J,358.3,7131,2)
 ;;=^322066
 ;;^UTILITY(U,$J,358.3,7132,0)
 ;;=V45.77^^46^490^1
 ;;^UTILITY(U,$J,358.3,7132,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7132,1,4,0)
 ;;=4^V45.77
 ;;^UTILITY(U,$J,358.3,7132,1,5,0)
 ;;=5^ACQ ABSENCE ORG,GENITALS
 ;;^UTILITY(U,$J,358.3,7132,2)
 ;;=^322067
 ;;^UTILITY(U,$J,358.3,7133,0)
 ;;=V45.78^^46^490^5
 ;;^UTILITY(U,$J,358.3,7133,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7133,1,4,0)
 ;;=4^V45.78
 ;;^UTILITY(U,$J,358.3,7133,1,5,0)
 ;;=5^ACQ ABSENCE ORGAN,EYE
